Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Bank fraud: ED...

    Bank fraud: ED attaches Rs 5.4 crore assets in Sterling biotech case

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-10-08T10:00:34+05:30  |  Updated On 8 Oct 2018 10:00 AM IST
    Bank fraud: ED attaches Rs 5.4 crore assets in Sterling biotech case

    NEW DELHI: The Enforcement Directorate has attached assets worth Rs 5.4 crore in connection with its probe in an alleged Rs 5,700-crore bank loan fraud case linked to a Gujarat-based pharmaceutical company.


    The attached immovable properties, one each in Faridabad and Gurgaon, belong to Delhi-based businessman Gagan Dhawan, who was arrested by the ED and is out on bail.

    A provisional order for attachment of the assets was issued by the agency under the Prevention of Money Laundering Act (PMLA).

    A similar order was passed against Dhawan by the agency in the past.
    The case relates to a money laundering case registered against the Sandesara brothers — Chetan Jayantilal Sandesara and Nitin Jayantilal Sandesara — and their Vadodara-based firm Sterling Biotech Limited and others on October 27 last year, two days after a case of bank fraud of Rs 5,700 crore and corruption was filed against them by the CBI.

    "Dhawan is accused of assisting and facilitating Nitin and Chetan Sandesara, directors and promoters of Sterling Biotech group, who are accused in the said bank loan fraud case," the central probe agency said in a statement.

    The investigation has revealed that Rs 5.4 crore was diverted from loan funds by Sandersara brothers and others and were subsequently given to Dhawan, it said.

    "Dhawan utilised these proceeds of crime to purchase and develop the said attached properties," it said.
    The businessman, it said, was "actively involved in the offence of money laundering."

    The agency is set to file a fresh, supplementary charge sheet in this case detailing the role of the Sandesara brothers.

    Read Also: In Sterling Biotech Case, Court Takes Note Of Chargesheet


    It has also notified the Interpol to obtain a global arrest warrant against them as they have left the country for an undisclosed location, with reports suggesting their location to be either in the UAE or Nigeria.


    The ED has filed a few chargesheets, called prosecution complaints, in this case in the past against other accused, including Dhawan.

    Read Also: ED to File Charge Sheet Against Sterling Biotech in Bank Loan Fraud Case of Over Rs 5000 Crore


    With the latest order, the total attachment in this case by the ED stands at Rs 4,710 crore, it said.

    The ED and the CBI have booked the company, its directors — the Sandesara brothers, DiChetan Sandesara, Rajbhushan Omprakash Dixit, Vilas Joshi, chartered accountant Hemant Hathi, former director Andhra Bank Anup Garg and a few unidentified persons in connection with the alleged bank fraud case.

    It is alleged that the company took loans of more than Rs 5,000 crore from a consortium led by Andhra Bank which had turned into non-performing assets.

    As per the FIR, the total pending dues of the group of companies were Rs 5,383 crore as on December 31, 2016.
    Andhra Bankbank fraud caseChetan Jayantilal SandesaraEDEnforcement DirectorateMoney LaunderingNigeriaNitin Jayantilal SandesaraNon-Performing AssetsNPAPMLAPrevention of Money Laundering ActRs 5700 CroreSandesara brothersSterling BiotechUAE
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok